Conceptus(CPTS Quote), which makes a permanent birth-control device called Essure, posted better-than-anticipated fourth-quarter results, but the company offered a 2006 outlook that was weaker than Wall Street expected.
The company's fourth-quarter loss narrowed to $4.4 million, or 15 cents a share, from $6.4 million, or 25 cents a share, a year earlier. Fourth-quarter sales were $6.8 million, up 87% from a year ago. Analysts polled by Thomson First Call were expecting a loss of 18 cents a share and sales of $6.4 million.
For the first quarter, Conceptus sees sales of $7.2 million to $7.4 million. The company also expects increased expenses in the quarter, resulting in a loss 17 cents to 18 cents a share, before stock-based compensation costs. Wall Street was looking for a first-quarter loss of 15 cents a share and sales of $7.75 million, according to a Thomson First Call survey of analysts. For all of 2006, the company expects a loss of 58 cents to 60 cents a share, before items, on sales of $33 million to $35 million. Analysts, on average, had forecast a loss of 49 cents a share, with sales of $35 million. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,366.15 | 1,099.92 | 2,173.14 | 33.80 |
Oil *
77.73
|
|
DOWN
86.53
|
DOWN
9.32
|
DOWN
11.89
|
UP
0.57
|
10 Yr
3.38%
SPDR Gold
118.70
|
|
-0.83%
|
-0.84%
|
-0.54%
|
+1.72%
|
Data delayed 20 minutes |


Connect with TheStreet